21 April 1999

ChemOvation launch - intriguing and innovative combinatorial chemistry

A new entrant to the drug discovery arena is ChemOvation (based in Horsham, West Sussex, UK). The group, which has a major backer in the Novartis Venture Fund, a strong supporter of exciting young technology companies, started operations in April 1999. They promise a range of innovative compound libraries to give the strongest possible lead-generating potential.

Science Director, Ian Matthews, with 20 years experience in drug discovery, is confident that ChemOvation has something unique to offer:

"Our research has shown that pharmaceutical companies need to speed up drug candidate realisation, and are looking for improved combinatorial chemistry services. All ChemOvation compound libraries have high purity levels and are supported by a distinctive physicochemical information package, which fills these criteria."

In addition to the core combinatorial chemistry business, ChemOvation has plans for other services. "We intend to offer characterisation services such as thermodynamic and kinetic analysis of binding events, and a metabolite identification service", says Linda Hugl, Operations Director. "And we shall also focus on reaching small-to-medium sized enterprises, with the aim of effectively becoming their chemistry department".

Further Information:

Dr Keith Menear

ChemOvation Ltd
Foundry Lane
Horsham
West Sussex, RH13 5PX
United Kingdom

Phone +44 (0)1403 248844
Fax +44 (0)1403 248855
Email:keith.menear@chemovation.com
Website: www.chemovation.com